Welcome to LookChem.com Sign In|Join Free
  • or
N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide, also known as Sulfanilamide-3,3-diacetic acid, is a chemical compound with a molecular formula C10H12N2O4S and a molecular weight of 260.28 g/mol. It is classified as an amide and a sulphonamide. N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide is recognized for its potential antimicrobial and antifungal properties and is a valuable building block in pharmaceutical research for the synthesis of potential drugs and bioactive molecules. Its diverse applications in medicine are currently under investigation, including its potential use in treating cancer, diabetes, and inflammatory conditions.

4542-32-9

Post Buying Request

4542-32-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4542-32-9 Usage

Uses

Used in Pharmaceutical Research:
N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide is used as a building block for the synthesis of potential drugs and bioactive molecules, leveraging its chemical properties to create new therapeutic agents.
Used in Antimicrobial Applications:
N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide is used as an antimicrobial agent for its potential to combat various types of infections due to its inherent antimicrobial properties.
Used in Antifungal Applications:
Similarly, it is used as an antifungal agent, indicating its potential to treat fungal infections and conditions.
Used in Cancer Treatment Research:
N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide is used as a potential anti-cancer agent in preclinical studies, where it has shown promising results in targeting cancer cells.
Used in Diabetes Treatment Research:
It is also being investigated for its potential role in diabetes treatment, suggesting a possible impact on managing blood sugar levels or related metabolic pathways.
Used in Inflammatory Condition Treatment Research:
Furthermore, N-[4-(aminosulphonyl)phenyl]-3-oxobutyramide is being explored for its potential to treat inflammatory conditions, indicating its possible anti-inflammatory effects.

Check Digit Verification of cas no

The CAS Registry Mumber 4542-32-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,4 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4542-32:
(6*4)+(5*5)+(4*4)+(3*2)+(2*3)+(1*2)=79
79 % 10 = 9
So 4542-32-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O4S/c1-7(13)6-10(14)12-8-2-4-9(5-3-8)17(11,15)16/h2-5H,6H2,1H3,(H,12,14)(H2,11,15,16)

4542-32-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Oxo-N-(4-sulfamoylphenyl)butanamide

1.2 Other means of identification

Product number -
Other names N-acetoacetyl-sulfanilic acid amide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4542-32-9 SDS

4542-32-9Relevant academic research and scientific papers

Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action

Fares, Mohamed,Eldehna, Wagdy M.,Bua, Silvia,Lanzi, Cecilia,Lucarini, Laura,Masini, Emanuela,Peat, Thomas S.,Abdel-Aziz, Hatem A.,Nocentini, Alessio,Keller, Paul A.,Supuran, Claudiu T.

, p. 3317 - 3326 (2020)

The design of three dual-tailed sulfonamide series 11a-11g, 14a-14h, and 16a-16e as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors are presented. All compounds were evaluated for inhibitory action against pharmacologically relevant human CA isoforms I, II, IV, and VII. Compounds 11a-11g emerged as potent CA inhibitors against the four tested isoforms with a significant selectivity to CA II, which is implicated in glaucoma (Ki in the range 0.36-6.9 nM). X-ray crystallographic analysis of three compounds (11a, 11d, and 11g) bound to CA II showed the validity of the adopted drug design strategy as specific moieties within the ligand structure interacted directly with the hydrophobic and hydrophilic halves of the CA II active site. Compounds 11b-11d and 11g were evaluated for their intraocular pressure-lowering effects in a rabbit model of glaucoma. 11b and 11d showed significant efficacy when compared to the clinically used drug dorzolamide.

Synthesis of β-Ketoamide Curcumin Analogs for Anti-Diabetic and AGEs Inhibitory Activities

Banuppriya, Govindharasu,Sribalan, Rajendran,Fathima, Sulthan Alavudeen Rizwan,Padmini, Vediappen

, (2018/08/03)

Two different series of novel β-ketoamide curcumin analogs enriched in biological activities have been synthesized. The synthesized compounds were screened for their in?vitro anti-diabetic and AGEs inhibitory activities and exhibited potent to good anti-diabetic and AGEs inhibitory activities. The molecular docking study was also performed with the α-amylase enzyme.

COMPOUND HAVING AZO SKELETON STRUCTURE, PIGMENT-DISPERSING AGENT, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER

-

Paragraph 0323, (2014/11/13)

The present invention provides a compound capable of improving the dispersibility of yellow, magenta, cyan, and black pigments in a water-insoluble solvent and a pigment-dispersing agent. The present invention also provides a pigment composition, a pigment dispersion, and a toner, which have satisfactory tinting strength. The present invention relates to a compound having a structure in which an azo skeleton structure is bound to a polymer portion via a linking group in the azo skeleton structure.

Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening

Osolodkin, Dmitry I.,Kozlovskaya, Liubov I.,Dueva, Evgenia V.,Dotsenko, Victor V.,Rogova, Yulia V.,Frolov, Konstantin A.,Krivokolysko, Sergey G.,Romanova, Ekaterina G.,Morozov, Alexey S.,Karganova, Galina G.,Palyulin, Vladimir A.,Pentkovski, Vladimir M.,Zefirov, Nikolay S.

supporting information, p. 869 - 874 (2013/10/01)

Flaviviruses form a large family of enveloped viruses affecting millions of people over the world. To date, no specific therapy was suggested for the infected people, making the treatment exclusively symptomatic. Several attempts were performed earlier for the design of fusion inhibitors for mosquito-borne flaviviruses, whereas for the tick-borne flaviviruses such design had not been performed. We have constructed homology models of envelope glycoproteins of tick-transmitted flaviviruses with the detergent binding pocket in the open state. Molecular docking of substituted 1,4-dihydropyridines and pyrido[2,1-b][1,3,5]thiadiazines was made against these models, and 89 hits were selected for the in vitro experimental evaluation. Seventeen compounds showed significant inhibition against tick-borne encephalitis virus, Powassan virus, or Omsk hemorrhagic fever virus in the 50% plaque reduction test in PEK cells. These compounds identified through rational design are the first ones possessing reproduction inhibition activity against tick-borne flaviviruses.

Synthesis of some more fluorine heterocyclic nitrogen systems derived from sulfa drugs as photochemical probe agents for inhibition of vitiligo disease-part i

Abdel-Rahman, Reda M.,Makki, Mohammad Saleh I.T.,Bawazir, Wafa A.

experimental part, p. 405 - 414 (2012/02/04)

Some more new bioactive fluorine heterocyclic systems containing sulfur and nitrogen as five-membered rings: pyrazoline, imidazole, imidazolopyrimidine, thiazolidinone and 1,2,4-triazole derivatives (3-13) have been synthetically derived from the interaction of sulfa drugs with fluorine aromatic aldehyde and/or hexa fluoroacetic anhydride followed by heterocyclization reactions. Former structures of the targets have been deduced upon the help of elemental and spectral data.. Compounds 7a-f, 10c and 13 could be used as photochemical probe agents for inhibition of Vitiligo diseases, in compare with Nystatin and Nalidixic acid.

Synthesis and biological evaluations of sulfa derivatives bearing heterocyclic moieties.

Abdel-Monem, Wafaa R

, p. 239 - 247 (2007/10/03)

Some new sulfa derivatives bearing a heterocyclic moieties fural, pyrimidinone, thiazolidinone, benzimidazole and 1,2,4-triazinone and the related compounds 2-19 have been synthesized from treatment of sulfa drugs with thioisocyanate, acid chlorides, 3-chloro-1,2,4-triazines, aldehydes, esters and/or 2-methylbenzoxazole followed by ring closure reactions. Structures of the products have been deduced from their elemental analysis and spectral data. Significant antimicrobial activities were observed in vitro for some members of the series. Compounds 9b, 16 are highly active, while compounds 4b, 6d, 7,9a, 10 and 14 showing a moderate active towards gramme positive bacterium (b.subtilis). gramme negative bacterium (E. coli) and two fungi namely (A.nidulans & A.terreus).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4542-32-9